Revista Brasileira de Cirurgia Plástica (Dec 2022)

Pyoderma gangrenosum: update and guidance

  • Luiz Felipe Duarte Fernandes Vieira,
  • Carlos Lacerda Andrade Almeida,
  • Alexandre Wagner de Souza,
  • Jozelia Rêgo,
  • Everton Siviero do Vale,
  • Jose Roberto Pereira Pegas

DOI
https://doi.org/10.5935/2177-1235.2022RBCP.671-en
Journal volume & issue
Vol. 37, no. 04
pp. 423 – 430

Abstract

Read online

Introduction: The pyoderma gangrenosum (PG) is a neutrophilic disease, rare but with a poor outcome. The Capitulum of Wound treatment of the Brazilian Society of Plastic Surgery (SBCP) promoted a discussion with the Brazilian societies of Dermatology and Rheumatology to extract the best procedures in diagnostic and treatment. Methods: Broad review of published articles related to the subject and compilation of guidelines of diagnostic and treatment by two advisors of each involved society, plastic surgery, dermatology and rheumatology. Results: The PG is not an exclusion disease anymore, with well defined criteria for its diagnostic and literature based treatment, refined by the authors, including the use of biological therapies. Conclusion: The PG remains challenging, but systematizing the investigation and the use of new drugs has opened a new horizon of treatments, interfering in the pathophysiology in a positive manner with fewer side effects than immunosuppressive therapy alone.

Keywords